Label Changes for:

Famvir (Famciclovir) Tablets

April 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013

 

ADVERSE REACTIONS

Postmarketing Experience
  • Skin and subcutaneous tissue disorders: leukocytoclastic vasculitis
  • Cardiac disorders: Palpitations

 

Hide
(web5)